首页> 外文期刊>The journal of sexual medicine >Erectile dysfunction in diabetes mellitus.
【24h】

Erectile dysfunction in diabetes mellitus.

机译:糖尿病的勃起功能障碍。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Type 2 diabetes is reaching pandemic levels and young-onset type 2 diabetes is becoming increasingly common. Erectile dysfunction (ED) is a common and distressing complication of diabetes. The pathophysiology and management of diabetic ED is significantly different to nondiabetic ED. AIM: To provide an update on the epidemiology, risk factors, pathophysiology, and management of diabetic ED. METHOD: Literature for this review was obtained from Medline and Embase searches and from relevant text books. MAIN OUTCOME MEASURES: A comprehensive review on epidemiology, risk factors, pathophysiolgy, and management of diabetic ED. RESULTS: Large differences in the reported prevalence of ED from 35% to 90% among diabetic men could be due to differences in methodology and population characteristics. Advancing age, duration of diabetes, poor glycaemic control, hypertension, hyperlipidemia, sedentary lifestyle, smoking, and presence of other diabetic complications have been shown to be associated with diabetic ED in cross-sectional studies. Diabetic ED is multifactorial in aetiology and is more severe and more resistant to treatment compared with nondiabetic ED. Optimized glycaemic control, management of associated comorbidities and lifestyle modifications are essential in all patients. Psychosexual and relationship counseling would be beneficial for men with such coexisting problems. Hypogonadism, commonly found in diabetes, may need identification and treatment. Maximal doses of phosphodiesterase type 5 (PDE5) inhibitors are often needed. Transurethral prostaglandins, intracavenorsal injections, vacuum devices, and penile implants are the available therapeutic options for nonresponders to PDE5 inhibitors and for whom PDE5 inhibitors are contraindicated. Premature ejaculation and reduced libido are conditions commonly associated with diabetic ED and should be identified and treated. CONCLUSIONS: Aetiology of diabetic ED is multifactorial although the relative significance of these factors are not clear. A holistic approach is needed in the management of diabetic ED.
机译:简介:2型糖尿病已达到大流行水平,年轻的2型糖尿病正变得越来越普遍。勃起功能障碍(ED)是糖尿病的常见且令人困扰的并发症。糖尿病性ED的病理生理和治疗与非糖尿病性ED明显不同。目的:提供有关糖尿病性ED的流行病学,危险因素,病理生理学和治疗的最新信息。方法:本综述的文献来自Medline和Embase搜索以及相关的教科书。主要观察指标:对糖尿病性ED的流行病学,危险因素,病理生理学和治疗进行全面回顾。结果:在糖尿病男性中,据报道的ED患病率从35%到90%存在较大差异,这可能是由于方法和人群特征的差异所致。在横断面研究中显示,年龄增长,糖尿病持续时间,血糖控制不良,高血压,高脂血症,久坐的生活方式,吸烟和其他糖尿病并发症的存在与糖尿病ED有关。与非糖尿病性ED相比,糖尿病性ED在病因学上是多因素的,并且更加严重并且对治疗具有更高的抵抗力。优化的血糖控制,相关合并症的管理和生活方式的改变对所有患者都是至关重要的。心理咨询和关系咨询对患有此类共存问题的男性有益。常见于糖尿病的性腺机能减退可能需要识别和治疗。通常需要最大剂量的5型磷酸二酯酶(PDE5)抑制剂。经尿道前列腺素,腔内注射,真空装置和阴茎植入物是对PDE5抑制剂无反应者和禁用PDE5抑制剂的可用治疗选择。早泄和性欲减退是糖尿病性ED的常见病因,应予以鉴定和治疗。结论:糖尿病性ED的病因是多因素的,尽管这些因素的相对意义尚不清楚。糖尿病性ED的管理需要整体方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号